Evogene's total assets for Q4 2025 were $20.05M, a decrease of -23.15% from the previous quarter. EVGN total liabilities were $5.00M for the fiscal quarter, a -16.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.